|
NEK9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.136400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.365800E-02 |
| Normal-vs-Stage2 |
3.459600E-01 |
| Normal-vs-Stage3 |
3.751800E-02 |
| Normal-vs-Stage4 |
5.209900E-02 |
| Stage1-vs-Stage2 |
5.895000E-01 |
| Stage1-vs-Stage3 |
5.890200E-01 |
| Stage1-vs-Stage4 |
6.196600E-01 |
| Stage2-vs-Stage3 |
3.628800E-01 |
| Stage2-vs-Stage4 |
3.894400E-01 |
| Stage3-vs-Stage4 |
8.854000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.184820E-01 |
| Normal-vs-AfricanAmerican |
6.718300E-02 |
| Normal-vs-Asian |
3.345600E-01 |
| Caucasian-vs-AfricanAmerican |
5.049800E-01 |
| Caucasian-vs-Asian |
8.905400E-01 |
| AfricanAmerican-vs-Asian |
9.203600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.958200E-02 |
| Normal-vs-Female |
2.985400E-01 |
| Male-vs-Female |
7.028800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.606300E-02 |
| Normal-vs-Extreme_Weight |
5.373700E-02 |
| Normal-vs-Obese |
5.256600E-01 |
| Normal-vs-Extreme_Obese |
2.673500E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.932800E-01 |
| Normal_Weight-vs-Obese |
3.325800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.180200E-01 |
| Extreme_Weight-vs-Obese |
2.629200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.358200E-01 |
| Obese-vs-Extreme_Obese |
2.401400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.773200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.556800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.297000E-03 |
| Normal-vs-Age(81-100Yrs) |
6.919800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.406800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.480100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.650300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.975700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.465800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.151200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.424800E-01 |
| Normal-VS-Type2 PRCC |
2.18119999995103E-06 |
| Normal-VS-KIRP CIMP |
9.040200E-01 |
| Normal-VS-Unclassified PRCC |
3.983400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.78100000303161E-08 |
| Type1 PRCC-VS-KIRP CIMP |
8.877600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.845600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.050800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.055200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.758600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.124700E-03 |
| Normal-vs-N1 |
6.102400E-01 |
| Normal-vs-N2 |
7.556300E-03 |
| N0-vs-N1 |
2.005800E-01 |
| N0-vs-N2 |
3.116600E-01 |
| N1-vs-N2 |
2.226800E-01 |
|
|
